{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:49:42Z","timestamp":1790171382232,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00259-025-07683-4","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:19:30Z","timestamp":1764152370000},"page":"3074-3081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A dual-tracer approach for enhanced nodal staging in prostate cancer: the role of [18F]FDG PET\/CT for detecting [68\u00a0Ga]Ga-PSMA-11-negative metastases"],"prefix":"10.1007","volume":"53","author":[{"given":"Ruohua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"7683_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353.","journal-title":"Int J Cancer"},{"key":"7683_CR2","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"7683_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.eururo.2013.03.053","volume":"65","author":"KA Touijer","year":"2014","unstructured":"Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol. 2014;65:20\u20135.","journal-title":"Eur Urol"},{"key":"7683_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 Update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243\u201362.","journal-title":"Eur Urol"},{"key":"7683_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","volume":"4","author":"GE Cacciamani","year":"2021","unstructured":"Cacciamani GE, Maas M, Nassiri N, Ortega D, Gill K, Dell\u2019Oglio P, et al. Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive systematic review and meta-analysis. Eur Urol Oncol. 2021;4:134\u201349.","journal-title":"Eur Urol Oncol"},{"key":"7683_CR6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208\u201316.","journal-title":"Lancet"},{"key":"7683_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.09.003","volume":"85","author":"DE Oprea-Lager","year":"2024","unstructured":"Oprea-Lager DE, MacLennan S, Bjartell A, Briganti A, Burger IA, de Jong I, et al. European association of nuclear medicine focus 5: consensus on molecular imaging and theranostics in prostate cancer. Eur Urol. 2024;85:49\u201360.","journal-title":"Eur Urol"},{"key":"7683_CR8","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50:1466\u201386.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7683_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2019.06.030","volume":"76","author":"A Paschalis","year":"2019","unstructured":"Paschalis A, Sheehan B, Riisnaes R, Rodrigues DN, Gurel B, Bertan C, et al. Prostate-specific membrane antigen heterogeneity and DNA repair defects in prostate cancer. Eur Urol. 2019;76:469\u201378.","journal-title":"Eur Urol"},{"key":"7683_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00259-019-04524-z","volume":"47","author":"W Cytawa","year":"2020","unstructured":"Cytawa W, Seitz AK, Kircher S, Fukushima K, Tran-Gia J, Schirbel A, et al. (68)Ga-PSMA I&T PET\/CT for primary staging of prostate cancer. Eur J Nucl Med Mol Imaging. 2020;47:168\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7683_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"M Perera","year":"2020","unstructured":"Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, et al. Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. Eur Urol. 2020;77:403\u201317.","journal-title":"Eur Urol"},{"key":"7683_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2023.12.016","author":"NA Huebner","year":"2024","unstructured":"Huebner NA, Wasinger G, Rajwa P, Resch I, Korn S, Rasul S, et al. Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET. Urol Oncol. 2024. https:\/\/doi.org\/10.1016\/j.urolonc.2023.12.016.","journal-title":"Urol Oncol"},{"key":"7683_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","volume":"75","author":"G Gandaglia","year":"2019","unstructured":"Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, et al. A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies. Eur Urol. 2019;75:506\u201314.","journal-title":"Eur Urol"},{"key":"7683_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2967\/jnumed.119.231068","volume":"61","author":"MK Bakht","year":"2020","unstructured":"Bakht MK, Lovnicki JM, Tubman J, Stringer KF, Chiaramonte J, Reynolds MR, et al. Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for (18)F-FDG imaging of PSMA-suppressed tumors. J Nucl Med. 2020;61:904\u201310.","journal-title":"J Nucl Med"},{"key":"7683_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-00640-2","volume":"10","author":"F Rosar","year":"2020","unstructured":"Rosar F, Ribbat K, Ries M, Linxweiler J, Bartholoma M, Maus S, et al. Neuron-specific enolase has potential value as a biomarker for [(18)F]FDG\/[(68)Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients. EJNMMI Res. 2020;10:52.","journal-title":"EJNMMI Res"},{"key":"7683_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D'Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969\u201374.","journal-title":"JAMA"},{"key":"7683_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.eururo.2023.06.008","volume":"84","author":"RA Werner","year":"2023","unstructured":"Werner RA, Hartrampf PE, Fendler WP, Serfling SE, Derlin T, Higuchi T, et al. Prostate-specific membrane antigen reporting and data system version 2.0. Eur Urol. 2023;84:491\u2013502.","journal-title":"Eur Urol"},{"key":"7683_CR18","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","volume":"195","author":"T Maurer","year":"2016","unstructured":"Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G, et al. Diagnostic efficacy of (68)Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol. 2016;195:1436\u201343.","journal-title":"J Urol"},{"key":"7683_CR19","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/pros.22831","volume":"74","author":"DE Spratt","year":"2014","unstructured":"Spratt DE, Gavane S, Tarlinton L, Fareedy SB, Doran MG, Zelefsky MJ, et al. Utility of FDG-PET in clinical neuroendocrine prostate cancer. Prostate. 2014;74:1153\u20139.","journal-title":"Prostate"},{"key":"7683_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/RLU.0000000000002252","volume":"43","author":"LL Brunette","year":"2018","unstructured":"Brunette LL, Bonyadlou S, Ji L, Groshen S, Shuster D, Mehta A, et al. Predictive value of FDG PET\/CT to detect lymph node metastases in cervical cancer. Clin Nucl Med. 2018;43:793\u2013801.","journal-title":"Clin Nucl Med"},{"key":"7683_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/01.mnm.0000171781.11027.bb","volume":"26","author":"P Castellucci","year":"2005","unstructured":"Castellucci P, Nanni C, Farsad M, Alinari L, Zinzani P, Stefoni V, et al. Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. Nucl Med Commun. 2005;26:689\u201394.","journal-title":"Nucl Med Commun"},{"key":"7683_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13550-025-01265-z","volume":"15","author":"MJ Roberts","year":"2025","unstructured":"Roberts MJ, Roberts NA, Pelecanos A, Yaxley JW, Harley SJD, Siriwardana AR, et al. A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer. EJNMMI Res. 2025;15:92.","journal-title":"EJNMMI Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07683-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:25:52Z","timestamp":1774401952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07683-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7683"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07683-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was in line with the principles of the ethics committee in Renji hospital and the declaration of Helsinki in 1964. Animal-based research was not included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflict of interest was reported.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}